NDC11 63323001041
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0010-41 | 63323-0010 |
| 63323-010-41 | 63323-010 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 84f5c763-1cd3-4d85-9afb-934db8666fbf | 2024-10-11 | Boxed warning, Warnings, Adverse reactions | 63323-010 |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 0cce2238-28d3-4280-b520-ffc3067a2ffa | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 63323-010-41 63323-010 63323001041 |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | a73a5453-c091-43fd-aae2-d992152363b1 | 2023-10-20 | Boxed warning, Warnings, Adverse reactions | 63323-010 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.